BusinessHealthcare Markets AVO refinancing deal delayed again By Maria Davies - 5th March 2024 FacebookTwitterPinterestWhatsAppLinkedin Advanced Oncotherapy (AVO) has announced further delays to its recapitalisation plans. The proton beam therapy developer had been expecting an initial tranche of funding in… You must be a HM Subscriber to view this content. Login » Subscribe Now »